EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal symptom and inflammatory trajectories with sublingual and allergoid-based subcutaneous immunotherapy in adults with asthma and allergic rhinitis

Jimena Prieto-Gomez, Ricardo Martinez-Tenopala, Sebastián Moreno Castro, Victor Gonzalez-Uribe, Maria Julia Rendon-Salazar, Cesar Fireth Pozo Beltran, Zaira S. Mojica-Gonzalez

Journal of Allergy and Clinical Immunology: Global · 2027-01 · 6 (1) · 100800

DOI: 10.1016/j.jacig.2026.100800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2027-01. Verfasst von Jimena Prieto-Gomez und 6 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term real-world comparative data on allergen immunotherapy modalities in adults with asthma and allergic rhinitis remain limited.

Objective

The aim of this study was to compare 24-month trajectories of symptom control, quality of life, and airway inflammation among adults receiving sublingual immunotherapy or allergoid-based subcutaneous immunotherapy in routine specialist care.

Methods

We conducted a retrospective single-center cohort study of adults with asthma, allergic rhinitis, and clinically relevant IgE-mediated aeroallergen sensitization treated with allergen immunotherapy. Of 242 treatment initiators, 180 completed the prespecified 24-month follow-up with complete longitudinal outcome capture. Outcomes included asthma control, asthma-related quality of life, rhinitis control, rhinoconjunctivitis-related quality of life, and fractional exhaled nitric oxide. Longitudinal trajectories were analyzed using generalized estimating equation models adjusted for baseline outcome value, age, sex, and baseline Global Initiative for Asthma treatment step.

Results

Baseline treatment intensity differed between groups. After adjustment, response trajectories differed across outcomes. Asthma control did not significantly differ between groups at 12 or 24 months. At month 12, asthma-related quality of life and rhinitis control favored allergoid-based subcutaneous immunotherapy, whereas rhinoconjunctivitis-related quality of life favored sublingual immunotherapy. By month 24, adjusted differences favored sublingual immunotherapy for asthma-related quality of life, rhinitis control, and fractional exhaled nitric oxide, whereas asthma control and rhinoconjunctivitis-related quality of life were not significantly different.

Conclusions

In this persistence-enriched real-world cohort of 24-month completers, both modalities were associated with sustained improvement. Comparative patterns varied by outcome domain and follow-up time and should be interpreted as longitudinal associations rather than causal estimates.

Zitieren

APA

Prieto-Gomez, J., Martinez-Tenopala, R., Castro, S. M., Gonzalez-Uribe, V., Rendon-Salazar, M. J., Beltran, C. F. P., & Mojica-Gonzalez, Z. S. (2027). Longitudinal symptom and inflammatory trajectories with sublingual and allergoid-based subcutaneous immunotherapy in adults with asthma and allergic rhinitis. Journal of Allergy and Clinical Immunology: Global, 6(1), 100800. https://doi.org/10.1016/j.jacig.2026.100800

Vancouver

Prieto-Gomez J, Martinez-Tenopala R, Castro SM, Gonzalez-Uribe V, Rendon-Salazar MJ, Beltran CFP, et al. Longitudinal symptom and inflammatory trajectories with sublingual and allergoid-based subcutaneous immunotherapy in adults with asthma and allergic rhinitis. Journal of Allergy and Clinical Immunology: Global. 2027;6(1):100800. doi:10.1016/j.jacig.2026.100800

BibTeX
@article{PrietoGomez2027,
  author = {Prieto-Gomez, Jimena and Martinez-Tenopala, Ricardo and Castro, Sebastián Moreno and Gonzalez-Uribe, Victor and Rendon-Salazar, Maria Julia and Beltran, Cesar Fireth Pozo and Mojica-Gonzalez, Zaira S.},
  title = {Longitudinal symptom and inflammatory trajectories with sublingual and allergoid-based subcutaneous immunotherapy in adults with asthma and allergic rhinitis},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2027},
  volume = {6},
  number = {1},
  pages = {100800},
  doi = {10.1016/j.jacig.2026.100800}
}
Kostenlos starten →